Incyte Genomics Inc
$INCY
Public valuation for Incyte Genomics Inc (INCY). Fair value, signal, and key metrics — no sign-in required.
Current Price
$123.22
Fairly Valued
Fair Value Estimate
$106
🚧
Turnaround
Negative earnings but showing signs of recovery
Analyst Consensus
Target: $127.12
3% higher than current
Key Metrics
Market Cap
$25.0B
Forward P/E
41.7x
Operating Margin
41.7%
Revenue Growth
29.2%
PEG Ratio
1.06
Get free watchlist alerts
Join the waitlist for valuation updates on $INCY and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.